When 31‑year‑old Zoë Armstrong finally saw an ultrasound confirming endometriosis, she burst into tears, relieved to have proof that her pain was real. Her story reflects a broader problem: many women wait ten years or more before receiving a diagnosis.
Why diagnosis is often delayed
The American College of Obstetricians & Gynecologists notes that endometriosis—a chronic inflammatory condition in which tissue similar to the uterine lining grows on other organs—affects roughly one in ten women worldwide. Symptoms vary widely, ranging from painful periods, painful intercourse, and painful bowel movements to fatigue, infertility, and severe abdominal pain.
Doctors and patients frequently normalize period pain, and the condition’s symptoms can mimic other disorders. As Dr. Megan Billow of the Cleveland Clinic explains, many healthcare providers lack specific training in recognizing endometriosis, contributing to delayed referrals and misdiagnoses.
Practical steps for patients
Experts recommend that women keep a detailed pain diary, noting when pain occurs, its location, and intensity. Bringing this record to a medical appointment can help clinicians consider endometriosis as a possible cause.
“When you come to the doctor, you come prepared,” says Dr. Drorit Or of Mount Sinai West in New York. “You can definitely ask: Do you think I have endometriosis?”
Emerging diagnostic tools abroad
Two new tests are gaining attention in the United Kingdom and other countries. The half‑hour EndoSure test measures electrical signals in the gut via sensor pads on the abdomen, while the Endotest analyzes a saliva sample for microRNAs linked to the disease. Both provide results faster than traditional imaging.
In the U.K., draft guidance suggests the National Health Service use these tools for a three‑year trial period while more data are collected. Their goal is to speed up primary‑care diagnosis.
U.S. prospects for new tests
EndoSure’s founder, Dr. Mark Noar of Maryland, is preparing an FDA application to bring the test to the United States as an aid for physicians. French company Ziwig is pursuing a laboratory‑developed pathway for Endotest, allowing certain certified labs to offer the test without full FDA clearance.
Dr. Andrew Spiers of Ziwig cautions that these tests are not stand‑alone solutions. “I would not say that it’s the only tool that a patient would have in their diagnostic pathway,” he says. U.S. doctors agree the tests could complement, but not replace, imaging and surgical evaluation.
Treatment options after diagnosis
Once diagnosed, women can work with their doctors on a range of treatments. Pain relievers such as ibuprofen, prescription medications specifically approved for endometriosis, hormonal therapies—including birth‑control pills, progestin, and GnRH agonists that temporarily halt periods—are common first steps. In severe cases, surgical options such as excision of lesions or, rarely, hysterectomy may be considered.
Armstrong, after undergoing excision surgery, continues to see multiple specialists weekly for pelvic‑floor therapy and other follow‑up care. She also volunteers with the Endometriosis Foundation, speaking at New York City schools to raise awareness.
Hope for the future
Doctors stress that living with endometriosis does not have to mean a life of constant pain. “You don’t have to live in pain,” Dr. Or affirms. “You can have a very, very good life managing this disease.” With improved diagnostic tools on the horizon and greater public awareness, the hope is that women will receive earlier, more accurate diagnoses and effective treatment plans.
Original reporting: WESH Orlando — read the source article.
